Net profit of Parenteral Drugs (India) reported to Rs 23.81 crore in the quarter ended March 2022 as against net loss of Rs 24.85 crore during the previous quarter ended March 2021. Sales declined 31.13% to Rs 1.77 crore in the quarter ended March 2022 as against Rs 2.57 crore during the previous quarter ended March 2021.For the full year,net loss reported to Rs 76.36 crore in the year ended March 2022 as against net loss of Rs 121.71 crore during the previous year ended March 2021. Sales declined 30.16% to Rs 8.50 crore in the year ended March 2022 as against Rs 12.17 crore during the previous year ended March 2021. ParticularsQuarter EndedYear Ended�Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var. Sales1.772.57 -31 8.5012.17 -30 OPM %-332.20131.91 --176.59-96.71 - PBDT-5.85-29.04 80 -121.19-137.15 12 PBT-33.00-33.36 1 -161.34-154.47 -4 NP23.81-24.85 LP -76.36-121.71 37 Powered by Capital Market - Live News

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 30 May 2022.Powered by Capital Market - Live News

Net Loss of Parenteral Drugs (India) reported to Rs 34.52 crore in the quarter ended December 2021 as against net loss of Rs 30.97 crore during the previous quarter ended December 2020. Sales declined 29.41% to Rs 1.44 crore in the quarter ended December 2021 as against Rs 2.04 crore during the previous quarter ended December 2020. ParticularsQuarter Ended�Dec. 2021Dec. 2020% Var. Sales1.442.04 -29 OPM %-223.61-140.69 - PBDT-39.90-34.95 -14 PBT-44.23-39.29 -13 NP-34.52-30.97 -11 Powered by Capital Market - Live News

Parenteral Drugs (India) will hold a meeting of the Board of Directors of the Company on 14 February 2022.Powered by Capital Market - Live News

Parenteral Drugs (India) announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 1 March 2022 .Powered by Capital Market - Live News